Infectious Diseases in Obstetrics and Gynecology

Infectious Diseases in Obstetrics and Gynecology / 1999 / Article

Open Access

Volume 7 |Article ID 724045 | https://doi.org/10.1155/S1064744999000411

G. R. G. Monif, "Semiquantitative Bacterial Observations With Group B Streptococcal Vulvovaginitis", Infectious Diseases in Obstetrics and Gynecology, vol. 7, Article ID 724045, 3 pages, 1999. https://doi.org/10.1155/S1064744999000411

Semiquantitative Bacterial Observations With Group B Streptococcal Vulvovaginitis

Received08 Jan 1999
Accepted21 Jun 1999

Abstract

Objective: Group B streptococcal (GBS) vulvovaginitis is a poorly-delineated clinical entity. The purpose of this study is to report semiquantitative data from four cases of GBS vulvovaginitis and to comment on their significance in terms of the in vitro inhibitory capabilities of GBS.Methodology: Four patients whose clinical presentations were consistent with GBS vulvovaginitis, from whom GBS was isolated and for whom semi-quantitative as well as qualitative microbiologic data existed, were identified.Results: To produce vulvovaginitis, GBS must be at a high multiplicity (108 CFU/g of vaginal fluid). Single coisolates were identified in three of the four cases (two cases of Escherichia coli and one case of Staphylococcus aureus). Group B streptococcus does not inhibit either of these bacteria in vitro.Conclusion: When the growth requirements for the demonstration of in vitro inhibition for GBS or lack thereof are met in vivo, the in vivo observations are consistent with those projected from the in vitro data. Infect. Dis. Obstet. Gynecol. 7:227–229, 1999.

Copyright © 1999 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Order printed copiesOrder
Views95
Downloads444
Citations

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.